Evaluation of calcium-binding protein A11 promotes the carcinogenesis of hypopharygeal squamous cell carcinoma via the PI3K/AKT signaling pathway

被引:0
作者
Wang, Chengyu [1 ]
Lin, Chen [1 ]
Tao, Qilei [1 ]
Zhao, Shuwei [1 ]
Liu, Huanhai [1 ]
Li, Li [1 ]
机构
[1] Second Mil Med Univ, Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, 415 Fengyang Rd, Shanghai 200003, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2019年 / 11卷 / 06期
基金
上海市自然科学基金;
关键词
S100A11; hypopharyngeal squamous cell carcinoma; PI3K/Akt/mTOR; migration; DOWN-REGULATION; S100; PROTEINS; SMOOTH-MUSCLE; EXPRESSION; CANCER; MIGRATION; PROLIFERATION; CALGIZZARIN; APOPTOSIS; GROWTH;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The S100 gene family encodes low molecular weight proteins implicated in cancer progression. In the present study, we explored the effects and underlying mechanisms of calcium-binding protein All (S100A11 protein) in hypopharyngeal squamous cell carcinoma (HSCC). Methods: RT-qPCR and western blot analysis were used to detect the mRNA and protein expression of S100A11, EGFR, MMP2, CD44, and MMP9. CCK-8, colony formation, wound healing and transwell invasion assays were performed to evaluate the effects of S100A11 on HSCC cells. Results: In our study, we observed that the level of S100A11 expression was significantly upregulated in HSCC tissues and cell lines. S100A11 inhibition increased the effects of 5-Fu on FaDu cells proliferation in vitro. In addition, S100A11 inhibition decreased the migration ability of FaDu cells. Additionally, the expression of migration-related proteins including EGFR, MMP2, CD44, and MMP9 were down-regulated when S100A11 was knocked down. Moreover, the expression of phosphorylated-PI3K (p-PI3K), phosphorylated-Akt (p-Akt), phosphorylated-mTOR (p-mTOR) and BCL-2 in FaDu cells were dramatically decreased. Conclusions: Our results suggested that S100A11 could activate the PI3K/AktimTOR signaling pathway in HSCC tumorigenesis.
引用
收藏
页码:3472 / 3480
页数:9
相关论文
共 28 条
  • [1] Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas
    Chen, WY
    Palanisamy, N
    Schmidt, H
    Teruya-Feldstein, J
    Jhanwar, SC
    Zelenetz, AD
    Houldsworth, J
    Chaganti, RSK
    [J]. ONCOGENE, 2001, 20 (52) : 7686 - 7693
  • [2] Selective expression of S100A11 in lung cancer and its role in regulating proliferation of adenocarcinomas cells
    Hao, Juanting
    Wang, Ke
    Yue, Yang
    Tian, Tian
    Xu, Anjian
    Hao, Jia
    Xiao, Xueyuan
    He, Dacheng
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 359 (1-2) : 323 - 332
  • [3] Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation
    Howell, Michael D.
    Fairchild, Heather R.
    Kim, Byung Eui
    Bin, Lianghua
    Boguniewicz, Mark
    Redzic, Jasmina S.
    Hansen, Kirk C.
    Leung, Donald Y. M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (09) : 2248 - 2258
  • [4] Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo
    Jiang, Hanguo
    Fan, Desheng
    Zhou, Gengyin
    Li, Xiaofang
    Deng, Huihua
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
  • [5] Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-κB Signaling Pathway
    Jin, Ye
    Qiu, Shuang
    Shao, Na
    Zheng, Jianhua
    [J]. MEDICAL SCIENCE MONITOR, 2018, 24 : 11 - 18
  • [6] Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours
    Kanamori, T
    Takakura, K
    Mandai, M
    Kariya, M
    Fukuhara, K
    Sakaguchi, M
    Huh, NH
    Saito, K
    Sakurai, T
    Fujita, J
    Fujii, S
    [J]. MOLECULAR HUMAN REPRODUCTION, 2004, 10 (10) : 735 - 742
  • [7] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Komatsu, Masanori
    Shiono, Osamu
    Taguchi, Takahide
    Sakuma, Yasunori
    Nishimura, Goushi
    Sano, Daisuku
    Sakuma, Naoko
    Yabuki, Kenichiro
    Arai, Yasuhiro
    Takahashi, Masahiro
    Isitoya, Junichi
    Oridate, Nobuhiko
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 416 - 421
  • [8] S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)
    Marenholz, I
    Heizmann, CW
    Fritz, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (04) : 1111 - 1122
  • [9] Melle C, 2006, INT J ONCOL, V28, P195
  • [10] Memon AA, 2005, CLIN CANCER RES, V11, P606